Plasma concentrations of persistent organic pollutants and pancreatic cancer risk

Author:

Porta Miquel123ORCID,Gasull Magda123,Pumarega José123,Kiviranta Hannu4,Rantakokko Panu4,Raaschou-Nielsen Ole5,Bergdahl Ingvar A67,Sandanger Torkjel Manning8,Agudo Antoni9,Rylander Charlotta8,Nøst Therese Haugdahl8,Donat-Vargas Carolina1011,Aune Dagfinn12,Heath Alicia K12,Cirera Lluís31314,Goñi-Irigoyen Fernando31516,Alguacil Juan317,Giménez-Robert Àlex12,Tjønneland Anne5,Sund Malin18,Overvad Kim19,Mancini Francesca Romana2021,Rebours Vinciane2223,Boutron-Ruault Marie-Christine2021,Kaaks Rudolf24,Schulze Matthias B2526,Trichopoulou Antonia27,Palli Domenico28,Grioni Sara29,Tumino Rosario30,Naccarati Alessio31,Panico Salvatore32,Vermeulen Roel33,Quirós J Ramón34,Rodríguez-Barranco Miguel334,Colorado-Yohar Sandra M31335,Chirlaque María-Dolores31314,Ardanaz Eva33637,Wareham Nick38,Key Tim39,Johansson Mattias40,Murphy Neil40,Ferrari Pietro40,Huybrechts Inge40,Chajes Veronique40,Gonzalez Carlos Alberto9,de-Mesquita Bas Bueno-41,Gunter Marc40,Weiderpass Elisabete40,Riboli Elio12,Duell Eric J42,Katzke Verena24,Vineis Paolo1231ORCID

Affiliation:

1. Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Catalonia, Spain

2. Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain

3. Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain

4. Department of Health Security, National Institute for Health and Welfare, Kuopio, Finland

5. Danish Cancer Society Research Center, Copenhagen, Denmark

6. Department of Biobank Research, Umeå University, Umeå, Sweden

7. Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

8. Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway

9. Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain

10. Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

11. Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid, CEI UAM+CSIC, Madrid, Spain

12. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK

13. Department of Epidemiology, Murcia Regional Health Council, IMIB—Arrixaca, Murcia, Spain

14. Department of Health and Social Sciences, University of Murcia, Murcia, Spain

15. Health Department of Basque Government, Public Health Laboratory in Gipuzkoa, San Sebastian, Spain

16. Health Research Institute Biodonostia, San Sebastian, Spain

17. University of Huelva, Huelva, Spain

18. Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden

19. Department of Public Health, Aarhus University, Aarhus, Denmark

20. CESP, Faculté de médecine (USVQ), Université Paris-Sud, INSERM, Université Paris-Saclay, Villejuif, France

21. Inserm UMR1018, Institut Gustave Roussy, Villejuif, France

22. Pancreatology Department, Beaujon Hospital, AP-HP, Clichy, France

23. Inserm UMR1149, DHU Unit, Paris-Diderot University, Paris, France

24. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

25. Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam, Rehbruecke, Nuthetal, Germany

26. Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany

27. Hellenic Health Foundation, Athens, Greece

28. Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network—ISPRO, Florence, Italy

29. Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

30. Cancer Registry and Histopathology Department, “Civic—M.P. Arezzo” Hospital, ASP Ragusa, Ragusa, Italy

31. Molecular and Genetic Epidemiology Unit, Italian Institute for Genomic Medicine (IIGM), Turin, Italy

32. Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy

33. Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands

34. Escuela Andaluza de Salud Pública (EASP), Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain

35. National Faculty of Public Health, University of Antioquia, Medellín, Colombia

36. Navarra Public Health Institute, Pamplona, Spain

37. IdiSNA, Navarra Institute for Health Research, Pamplona, Spain

38. MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK

39. Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK

40. International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France

41. Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

42. Oncology Data Analytics Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain

Abstract

Abstract Background Findings and limitations of previous studies on persistent organic pollutants (POPs) and pancreatic cancer risk support conducting further research in prospective cohorts. Methods We conducted a prospective case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Participants were 513 pancreatic cancer cases and 1020 matched controls. Concentrations of 22 POPs were measured in plasma collected at baseline. Results Some associations were observed at higher concentrations of p, p’-DDT, trans-nonachlor, β-hexachlorocyclohexane and the sum of six organochlorine pesticides and of 16 POPs. The odds ratio (OR) for the upper quartile of trans-nonachlor was 1.55 (95% confidence interval 1.06-2.26; P for trend = 0.025). Associations were stronger in the groups predefined as most valid (participants having fasted >6 h, with microscopic diagnostic confirmation, normal weight, and never smokers), and as most relevant (follow-up ≥10 years). Among participants having fasted >6 h, the ORs were relevant for 10 of 11 exposures. Higher ORs were also observed among cases with microscopic confirmation than in cases with a clinical diagnosis, and among normal-weight participants than in the rest of participants. Among participants with a follow-up ≥10 years, estimates were higher than in participants with a shorter follow-up (for trans-nonachlor: OR = 2.14, 1.01 to 4.53, P for trend = 0.035). Overall, trans-nonachlor, three PCBs and the two sums of POPs were the exposures most clearly associated with pancreatic cancer risk. Conclusions Individually or in combination, most of the 22 POPs analysed did not or only moderately increased the risk of pancreatic cancer.

Funder

Government of Catalonia

Publisher

Oxford University Press (OUP)

Subject

General Medicine,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3